Early concussion treatment tied to faster recovery | News | The Mighty 790 KFGO – KFGO News

Friday, January 10, 2020 4:10 p.m. CST

By Lisa Rapaport

(Reuters Health) - Young athletes who get concussions may recover faster when they're treated within the first week than when they wait longer to get care, a new study suggests.

Researchers examined data on 162 athletes ages 12 to 22who were diagnosed with concussions. Recovery time averaged 57 days, and ranged from 9 to 299 days.

Compared with athletes who started treatment within a week, those who didn't receive care that quickly were over four times more likely to have a recovery that took more than 30 days, the study found.

"There was an assumption that only patients with more severe symptoms and impairment following concussion would benefit from early care, which typically involved prescribed rest and restricted activities," said lead author Anthony Kontos, research director of the Sports Medicine Concussion Program at the University of Pittsburgh Medical Center.

"However, our research shows that regardless of symptoms and impairments, patients who seek specialty care earlier have better outcomes and recover sooner than those who seek care later."

A concussion is a traumatic brain injury caused by a jolt to the head or body that disrupts the function of the brain. This injury can result in physical, cognitive, emotional or sleep-related symptoms that may or may not involve a loss of consciousness. The symptoms can last from several minutes to days, weeks, months or longer.

More than half of athletes who sustain concussions don't receive care beyond an initial evaluation or diagnosis around the time of injury, researchers note in JAMA Neurology.

In the current study, recovery times from when athletes started follow-up concussion care were similar, suggesting that differences in recovery trajectories were due to the number of days they waited to begin treatment.

At their first follow-up checkups, athletes who received care within a week and those who took longer to start treatment had similar symptom severity as well as similar levels of impairment in areas like cognitive ability, vision, sleep and balance.

Later initiation of treatment as well as more severe vision and motion-related symptoms at diagnosis were both associated with much longer recovery times.

One limitation of the study is that researchers lacked data on how closely athletes followed any prescribed treatments or rehabilitation programs, how soon athletes returned to practice or competition, and how quickly they resumed regular academic work. All these factors could influence concussion recovery time.

Athletes may be advised on when to resume exercise or school work based on the severity of their injuries and their progress in treatment, said Jingzhen Yang of the Center for Injury at Nationwide Children's Hospital in Columbus, Ohio.

"Specifically, athletes may be advised on things they should avoid, such as strict rest or excessive physical activity, as these could result in increased symptoms or delayed recovery," Yang, who wasn't involved in the study, said by email. "Athletes may also be encouraged to engage in the symptom-limited, light physical activity as these could help mitigate symptoms and hasten concussion recovery."

Earlier treatment may help athletes receive therapy targeted to their specific combination of symptoms, which might include some mix of anxiety, mood swings, sleep difficulties, balance problems, dizziness, vision impairment, attention deficits and cognitive problems.

Although the study didn't explain why some athletes waited longer than others for care, it's possible many either were unaware of the need for rapid follow-up treatment or were unable to find or afford specialists, Yang said.

"It is imperative that student-athletes and parents understand that delayed presentation for clinical care after concussion may result in prolonged symptom duration, whereas early presentation for clinical care after concussion may lead to a shorter symptom duration and recovery time," Yang said.

SOURCE: https://bit.ly/30a5Nb9 JAMA Neurology, online January 6, 2020.

Read the original:
Early concussion treatment tied to faster recovery | News | The Mighty 790 KFGO - KFGO News

Satralizumab Is Highly Effective in Preventing… : Neurology Today – LWW Journals

Article In Brief

Satralizumab was effective in controlling relapses in patients with neuromyelitis optica spectrum who continued to take other immunosuppressant therapies during the trial.

Newly published phase 3 trial results for satralizumab add to growing excitement over the expanding treatment options for neuromyelitis optica spectrum disorder (NMOSD), a rare and debilitating autoimmune disorder for which there were no approved drugs until several months ago.

Eculizumab was cleared for marketing by the US Food and Drug Administration (FDA) in June for treatment of NMOSD, while satralizumab and another drug, inebilizumab are expected to get FDA approval in 2020.

The new study, published November 28, 2019, in The New England Journal of Medicine (NEJM), assessed satralizumab in NMOSD patients who continued to take other immunosuppressant therapies during the trial.

Results of another clinical trial that compared satralizumab alone to placebo were presented this past summer at the European Committee for Treatment and Research in Multiple Sclerosis, and both sets of trial findings have been submitted to the FDA as part of an application by Genentech to market the drug for NMOSD.

NMOSD, which is characterized by inflammatory lesions that mostly affect the optic nerve and spinal cord, can lead to mobility problems, paralysis and blindness, as well as death.

Satralizumab, eculizumab, and inebilizumab all are monoclonal antibody therapies, but they have different mechanisms of action.

Satralizumab, which is administered subcutaneously, targets the receptor for interleukin-6, an inflammatory factor that is believed to be key in NMOSD and is found to be elevated in the spinal fluid of persons with the disorder.

The more medications we have that effectively target different aspects of the of the pathologic autoimmunity in NMOSD, the better it is for patients, said Stacey Clardy, MD, PhD, assistant professor of neurology at University of Utah and staff neurologist at the Salt Lake City VA, who was not involved with the current study.

As more medications are approved, even a patient who may have contraindications or intolerable side effects from one therapy will have more choices for an effective treatment that is right for them, Dr. Clardy said.

Up until now, various immunotherapies, including rituximab, have been used off-label to prevent and treat the recurrent attacks associated with NMOSD, though up to 50 percent or more of patients continue to have attacks despite taking medication. Disability can result from one attack and worsen with each relapse, the authors of the study noted.

About two-thirds of NMOSD patients have antibodies against the water channel protein, aquaporin-4 (AQP4-IgG) that is involved in the inflammatory cascade. A positive AQP4 status is associated with more severe disease and also seems to be a favorable factor in whether patient benefit from the new targeted therapies.

The new study, led by researchers in Japan and involving patients in multiple countries, included both APQ4-positive and APQ4-negative patients, ages 12 to 74. Patients were eligible to participate if they had had at least two relapses in the two years prior to screening, including one relapse in the previous 12 months.

The trial, known as SAkuraSky, assigned 83 participants to either satralizumab at a dose of 120 mg or placebo as add-on therapy. The drugs were administered subcutaneously at the start and again at weeks two and four and every four weeks after that. Patients kept taking their usual immunosuppressant treatment. (The two most common were oral glucocorticoids and azathioprine.)

The primary endpoint was protocol-defined relapse. Secondary endpoints included change from baseline to week 24 in the visual-analogue scale for painscores range 0 to 100, with higher scores indicating more painand the Functional Assessment of Chronic Illness Therapy-Fatigue score, which has a range of 0 to 52, with higher scores indicating more fatigue.

Relapse occurred in eight patients receiving satralizumab (20 percent) compared with 18 patients on placebo (43 percent). That amounted to a 62 percent reduction in risk of relapse for those on satralizumab, the researchers reported.

The percentage of patients who were free of relapse at 48 weeks was 89 percent in the satralizumab group and 66 percent in the placebo group. At 96 weeks, those numbers were 78 percent and 59 percent, respectively, the report said. The median treatment duration with satralizumab was 107.4 weeks.

The drug was most effective in patients who tested positive for the APQ4-IgG antibody; that group had a 79 percent reduction in risk of relapse compared with those taking placebo. In patients who were APQ4-IgG negative, risk reduction was lower, 34 percent, compared with placebo.

There was no difference between the treatment and placebo groups when it came to pain and fatigue as measured by the two assessment tools. Rates of serious adverse events and infections also did not differ between the active drug and placebo group, the report said.

The trial had limitations, including the fact that it was relatively small and there was no active comparator, the researchers noted. Without a head-to-head comparison, it is impossible to say, for instance, which of the three new targeted drugs is most beneficial. The trial also was unable to say whether there was a difference between the two groups at any given week of treatment, the report said.

Longer and larger trials are necessary to determine the efficacy, durability, and safety of satralizumab and to investigate its effect in comparison with other treatments for NMOSD, the study concluded.

The study's lead author Takashi Yamamura, MD, PhD, director of the National Institute of Neuroscience in Japan, said in an email to Neurology Today that while head-to-head comparisons are needed, there could be a practical advantage for satralizumab, which allows patients to stay at home for continuous treatments, without going to hospital to receive intravenous infusions.

He added, however, that whether a patient gets the drug at home or in a health-care setting could vary from country to country.

Dr. Clardy agreed with the potential for a convenience factor. For patients to be able to avoid traveling to infusion centersor even the planning and hours spent on home infusion visitsthe option for a subcutaneous injection will potentially be a significant improvement in quality of life, especially when compared to therapies that require frequent intravenous infusions, she said.

Dr. Clardy said the much better results for satralizumab in APQ4- positive patients suggest we still have a lot of research to do to determine the ideal treatment for the patients who are either positive for the MOG antibody or double negative for AQP4 and MOG. MOG is another antibody associated with NMOSD.

Steven L. Galetta, MD, FAAN, professor and chair of neurology at NYU Langone Health, said the newly published study on satralizumab is incredibly exciting...because now we have three emerging therapies for NMOSD in one year. There was a time we thought it would be impossible to do a study in NMOSD because the number of patients with it is very small and we thought enrollment would fail.

But he cautioned that the new study results in NEJM are somewhat muddied by the fact that patients in the current trial continued to take their standard immunosuppressants. He also questioned predictions that doctors and patients will quickly embrace the new monoclonal therapy drugs in a big way.

I still think most doctors are going to go with rituximab first. It is going to be relatively cheaper for one thing, Dr. Galetta said, noting that small studies have shown that 70-80 percent of people can be relapse free on that drug.

If someone is doing really well on a current therapy, doctors are not going to be switching them out, Dr. Galetta said, though he said having more options is always a good thing since patients may fail one therapy but respond to another.

Michael Levy, MD, PhD, FAAN, associate professor of neurology at Harvard Medical School and director of the Neuromyelitis Optica Clinic and Research Laboratory at Massachusetts General Hospital, said it remains to be seen how the three new drugs are going to be incorporated into our routine. Are we going to take stable patients and convert them to an FDA-approved drug?

Dr. Levy said, My approach tends to be if a patient is stable for at least three years, I don't rock the boat. The truth is the drugs we use off-label are fairly effective and all are relatively well tolerated.

Dr. Levy said he was initially an investigator for the satralizumab study reported in NEJM but his site failed to recruit any patients. He helped in the design of the trial and served on the scientific advisory board for Genentech. He also was an investigator for clinical trials involving eculizumab (PREVENT study) and inebilizumab (NMOmentum) in NMOSD.

He said studies on all three new drugs demonstrated that [AQP4] seropositive patients are different from seronegative patients, he said, which indicates that more work remains to be done to find treatments that benefit antibody-negative patients.

Dr. Levy said it is nonetheless encouraging that evidence continues to build that we took a disease that causes disabling attacks and now can prevent a large number of relapses.

Dr. Takashi served on scientific advisory boards for and has received speaker honoraria from Novartis, Takeda, and Sumitomo Dainippon. He has received fees for speaking for Chiome Biosciencem Mitsubishi Tanabe, Bayer, Japan Blood Products Organization, Otsuka, Kissei, Daiichi Sankyo, and Miraca Holdings.

Read the rest here:
Satralizumab Is Highly Effective in Preventing... : Neurology Today - LWW Journals

Neurology Care | Neurological Disorder Treatment | UCHealth

At UCHealth, our neurology specialists provide expert care for a broad spectrum of neurological disorders, including concussion and back, neck, and spine careas well as nationally-certified, rapid-response stroke care.

We combine a patient-centered approach with advanced technology, research, and education to deliver the highest quality neurological and neurosurgical care in the Rocky Mountain region.

Our experienced neurology team diagnoses and treats a variety of neurological disorders, including epilepsy, movement disorders, multiple sclerosis and other neuroimmune diseases, as well as cancers of the brain and nervous system. We use a collaborative approach through emerging and proven therapies to ensure you receive the best possible care, and anticipate complications and address them before they become critical.

We want you, your family and your caregivers to be involved in any decisions about the care you receive at UCHealth. We listen to all of your concerns and answer any questions you may have to ensure youre comfortable and confident in all aspects of your carefrom communication with our doctors and staff to the level of quiet in your treatment room.

Whenever possible, your appointments are set for a single location and coordinated for the same day, allowing us to provide convenient, team-based care involving multiple specialists. Wherever you receive care, youll benefit from precision technology guided by knowledgeable, caring hands.

View UC Denver Clinical Research

View MCR and PVH Neurosciences Research

What to expect in the emergency room

Once youre stable, youre admitted to a hospital neuro ICU or stroke care unit for further observation, evaluation, and intensive medical management to start on the road to recovery. Its a short staytypically about two daysas we monitor your condition by checking:

Under the guidance of our physical medicine doctors (physiatrists) and other therapeutic specialists, you begin the stroke recovery and rehabilitation process right away.

And although youll leave our hospital and get back to your life as quickly as possible, youll never leave our care. After you return home, we continue to provide medical management and follow-up services, including access to stroke support groups for you and your family.

Dedicated stroke care in the hospital

Stroke recovery and rehabilitation

Our stroke rehabilitation team helps you recover as much function as possible while you retrain your body and adapt to any changes you experience. You may receive care from any of our specialists, including:

Stroke tests and treatments

We take these scans almost immediately when you get to the hospital, so we have time to evaluate your specific situation and make decisions about your treatment options.

Stroke treatments include:

Cerebrovascular disease treatments include:

More stroke information and resources

Anyone can experience a stroke. Some risk factors are beyond your control, including age, gender, race, family history, previous stroke or TIA, fibromuscular dysplasia, and PFO or hole in the heart. Thats why the National Stroke Associationrecommends reducing your chance of stroke by treating the many risk factors you can control, including:

Stroke prevention is still the best medicine. The most correctable conditions linked to stroke are:

What to Know About TIA and Stroke (PDF)

LEAP Program for Stroke Survivors and Caregivers

' + 'Boulder, CO 80303' + '

' + '

' + '

Monday:8am - 5pm

Tuesday:8am - 5pm

Wednesday:8am - 5pm

Thursday:8am - 5pm

Friday:8am - 5pm

Saturday:Closed

Sunday:Closed

' + 'View info' + '

' + '

' + '1107 S. Lemay Avenue' + '

' + 'Suite 240 ' + '

' + 'Fort Collins, CO 80524' + '

' + '

' + '970.495.7424' + '

' + 'View info' + '

' + '

' + '2500 Rocky Mountain Avenue' + '

' + 'Suite 340' + '

' + 'Loveland, CO 80538' + '

' + '

' + '970.203.7179' + '

' + 'View info' + '

' + '

' + '1635 Aurora Court' + '

' + 'Anschutz Outpatient Pavilion, 5th floor' + '

' + 'Aurora, CO 80045' + '

' + '

' + '720.848.2160' + '

' + '

Monday:8am - 4:30pm

Tuesday:8am - 4:30pm

Wednesday:8am - 4:30pm

Thursday:8am - 4:30pm

Friday:8am - 4:30pm

Saturday:Closed

Sunday:Closed

' + 'View info' + '

' + '

' + '1635 Aurora Court' + '

' + 'Anschutz Outpatient Pavilion, 6th floor' + '

' + 'Aurora, CO 80045' + '

' + '

' + '

Monday:8am - 5pm

Tuesday:8am - 5pm

Wednesday:8am - 5pm

Thursday:8am - 5pm

Friday:8am - 5pm

Saturday:Closed

Sunday:Closed

' + 'View info' + '

' + '

' + '9548 Park Meadows Drive' + '

' + 'Lone Tree, CO 80124' + '

' + '

' + ' 720.553.0901' + '

' + '

Monday:8am - 4:30pm

Tuesday:8am - 4:30pm

Wednesday:8am - 4:30pm

Thursday:8am - 4:30pm

Friday:8am - 4:30pm

Saturday:Closed

Sunday:Closed

' + 'View info' + '

' + '

' + '5050 Powderhouse Road' + '

' + 'Cheyenne, WY 82009' + '

' + '

' + '307.634.1271' + '

' + '

Monday:7:15am - 5pm

Tuesday:7:15am - 5pm

Wednesday:7:15am - 5pm

Read the rest here:
Neurology Care | Neurological Disorder Treatment | UCHealth

Neurology | Central Vermont Medical Center – Berlin, VT

Our Neurology providers offer comprehensive, compassionate care in the evaluation and treatment of adults and adolescents who present with a variety of neurological symptoms, disorders, abnormal findings on neurological examination and concerning findings on neuroimaging studies.

An Electroencephalogram (EEG) is a technique for studying the electrical current within the brain. Electrodes are attached to the scalp. Wires attach these electrodes to a machine which records the electrical impulses. The results are displayed on a computer screen. The electrical impulses are then viewed and interpreted by a neurologist.

The test is performed by attaching electrodes to the scalp with a paste. You may be asked to lie down and relax. During part of the test you will be exposed to a flashing light (photic stimulation) and/or asked to breath deeply and rapidly (hyperventilation). Some patients are asked to stay up all night before the test. Your referring physician will determine these special instructions. Under normal conditions, the test will take about an hour to conduct.

Preparing for the EEG:

Originally posted here:
Neurology | Central Vermont Medical Center - Berlin, VT

Neurology Journals Impact Factor List | Neurology Open …

List of Neuroscience Conferences 3rd International Conference on Spine and Spinal Disorders June 11-12, 2018 London, UK25th World Congress on Neurology & Neuroscience June 18-19, 2018 Dublin, Ireland6th International Conference on Neurodegenerative Disorders & Stroke July 05-06 2018 Vienna, Austria4th International Conference on Neurological Disorders & Stroke July 09-10, 2018 Sydney, Australia29th International Conference on Public Mental Health and Neuroscience July 16-18, 2018 Dubai, UAE25th World Congress on Neurology and Neurodisorders July 16-17, 2018 Melbourne, Australia7th World Congress on Addictive Disorders & Addiction Therapy July 16-18, 2018 London, UK4th Global Congress on Spine and Spinal Disorders September 05-06, 2018 Auckland, Newzealand25th International Conference on Psychiatric Disorders & Psychosomatic Medicine July 20-21, 2018 Sydney, Australia11th International Conference on Vascular Dementia July 23-25, 2018 Moscow, Russia27th Euro-Global Neurologists Meeting July 23 - 25, 2018 Moscow, Russia24th International Conference on Neuroscience and Neurochemistry July 23-24, 2018 || Birmingham, UK26th European Neurology Congress August 06-08, 2018 Madrid, SpainNeurology-2018 Osaka, JapanInternational conference on Cannabis and Medicinal Research Manila, PhilippinesNeuro ophthalmology 2018 Singapore City, SingaporePediatric Neurologists 2018 New Delhi, Indianeurocongress-2018 Osaka, Japandementia-2018 Osaka, Japan12th World Congress on Dementia and Alzheimer Rehabilitation November 27-29, 2018 Athens, GreeceInternational conference on Dual Diagnosis and Disorders November 14-15, 2018 Melbourne, Australia31st Clinical Neuroscience and Neurogenetics Conference: Mobilizing Neurons to Rehabilitate August 13-14, 2018 Dubai, UAE29th International Conference on Psychiatry & Mental Health September 14-15, 2018 Singapore City, Singapore3rd International Congress on Addictive Behavior & Dual Diagnosis August 16-17, 2018 Stockholm, Sweden8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry August 27-28, 2018 Tokyo, Japan4th World Congress on Parkinsons & Huntington Disease August 29-30, 2018 Zurich, Switzerland4th International Conference on Epilepsy & Treatment August 29-30, 2018 Zurich, SwitzerlandWorld Summit on Heart, Stroke & Neurological Disorders August 31-September 01, 2018 Boston, USA14th World Summit on Alzheimers Disease, Dementia Care Research and Awareness August 31-September 01, 2018 Boston, USAInternational Conference on September 10-12, 2018 Dublin, IrelandWorld Neuron Congress September 13-15, 2018 Bucharest, Romania6th International Conference on Brain Disorders and Therapeutics September 13-15, 2018 Copenhagen, DenmarkInternational Child and Adult Behavioural Health Conference September 13-14, 2018 Dubai, UAE3rd International Conference on Neuro-Oncology and Brain Tumor September 14-15, 2018 Singapore City, SingaporeWorld Congress on Epilepsy and Treatment September 17-18, 2018 Cape Town, South Africa12th World Congress on Advances and Innovations in Dementia September 17-18, 2018 Singapore City, Singapore25th International Conference on Neurochemistry and Neuropharmacology September 17-18, 2018 Dubai, UAEDementia 2018 Dublin, Ireland8th International Conference on Dementia and Dementia Care September 18-19, 2017 Dublin, Ireland4th World Congress on Epilepsy and Nervous system Disorders September 19-20, 2018 Singapore City, Singapore18th Global Neuroscience Conference September 19-20, 2018 Tokyo, JapanInternational Conference on Neurology & Health Care September, 20-22 Lisbon, PortugalAnnual Congress on Neurology & Neuroscience September 20-21, 2018 Prague, Czech Republic3rd International Conference on Neurooncology and Neurosurgery September 20-21, 2018 Dubai, UAE7th International Conference on Neurological Disorders & Stroke September 20-21, 2018 Rome, Italy8th International Congress on Stroke and Brain Haemorrhage Sep 20-21, 2018 Prague, Czech Republic12th Global Neurologists Meeting on Neurology and Neurosurgery September 21-22, 2018 Singapore City, Singapore3rd International Conference on Neuropsychiatry and Sleep Medicine September 21-22, 2018 Philadelphia, USA8th International Conference on Cognitive Science, Brain Disorders and Research September 21-22, 2018 Philadelphia, USA28th World Summit on Neurology, Neuroscience and Neuropharmacology September 26-27, 2018 Montreal, CanadaInternational Conference on Neuroimmunology, Neurological disorders and Neurogenetics September 26-27, 2018 Montreal, Canada3rd World Congress on Pediatric Neurology and Pediatric Surgery October 01-02, 2018 Osaka, Japan3rd International conference on Neuroscience, Neuroradiology & Imaging October 03-04, 2018 Osaka, Japan25th Cognitive Neuroscience Congress October 11-13, 2018 Dubai, UAE30th International Conference on Psychiatry and Mental Health October 11-12, 2018 Dubai, UAE27th International Conference on Neurology and Cognitive Neuroscience October 18-19, 2018 Warsaw, PolandNeurodegenerative and Neuroinflammation Conference: From Discovery to Health October 18-20, 2018 Helsinki, Finland5th International Conference on Parkinsons disease and Movement Disorders October 19-20, 2018 New York, USA5th Annual Conference on Stroke and Neurological Disorders October 22-23, 2018 Istanbul, Turkey12th International Conference on Alzheimers Disease & Dementia October 29-31, 2018 Valencia, Spain28th Global Neurologists Annual Meeting on Neurology and Neurosurgery November 01-03, 2018 Brussels, Belgium4th International Conference on Spine Surgery November 1-2, 2018 Brussels, BelgiumInternational Conference on Bipolar Disorder: Psychiatry and Mental Health November 8-10, 2018 Abu Dhabi, UAE30th International Conference on Mental and Behavioral Health November 12-13, 2018 Melbourne, Australia4th International Conference on Spine and Spinal Disorders November 12-13, 2018 Frankfurt, Germany9th International Conference on Addiction & Psychiatry November 12-13, 2018 Dubai, UAE4th International Conference on Central Nervous System Disorders & Therapeutics November 12-13, 2018 Edinburgh, Scotland8th International Conference on Psychoneuroimmunology November 15-16, 2018 Dubai, UAEInternational Conference on Neurology & Mental Disorders Nov 27-29, 2018 Athens, Greece26th International Conference on Psychiatric Disorders & Psychosomatic Medicine December 5-6, 2018 Dubai, UAEWorld Brain Congress December 5-7, 2018 Dubai, UAE13th Annual Conference on Dementia and Alzheimers Disease December 13-15, 2018 Abu Dhabi, UAEAnnual Congress and Expo on Cognitive Science and Artificial Intelligence Research San Francisco, USAVascular Dementia 2019 Paris, France 22nd World Congress on Neurology and Therapeutics February 28 March 02, 2019 Berlin, Germany

Read more here:
Neurology Journals Impact Factor List | Neurology Open ...

UH Neurological Institute | University Hospitals Parma …

Serving Parma and Clevelands west side, University Hospitals Neurological Institute at UH Parma Medical Center provides innovative, integrated and individualized care to patients with disorders of the nervous system.

Not all hospitals are equipped to diagnose and treat complex neurological conditions. But UH Neurological Institute at UH Parma Medical Centers provides superior neurological care at a convenient location. Recognized by U.S. News and World Report as one of the best programs in the country, UH Neurological Institute and its experts in neurology, neurosurgery and other specialties work together to devise customized care plans that leverage the latest medical advances and technologies.

Our nationally recognized physicians treat a wide variety of conditions related to the brain and nervous system. Some of the most common include:

UH Neurological Institute at UH Parma Medical Center has direct access to the same team of specialists, leading-edge technology and medical resources available at UH Neurological Institutes hub at University Hospitals Cleveland Medical Center. This ensures the same high-quality level of care, regardless of location.

Read more here:
UH Neurological Institute | University Hospitals Parma ...

Neurology | Neurology in Louisville | UofL Physicians

Patients who experience neurological challenges are faced with an array of complex decisions concerning their care and treatment. The care and support required extends far beyond the needs of the patient because with neurological disorders, family members and loved ones also experience changes that impact their daily lives. UofL Physicians -Neurology compriseshighly trained neurologists in Louisville who specialize in conditions that negatively affect the brain and nervous system as a result of injury or disease.

Additionally,UofL Physicians - Child Neurology has a team of specialists trained specifically in pediatric neurology. At UofL Physicians - Neurology, we diagnose and treat disorders that affect the brain, spinal cord, muscles and nerves throughout the body. Our array of specialized clinical services, including evaluation and management, second opinions for complex cases and diagnostic testing allows us to provide services for both minor disorders and patients who are critically ill.

The UofL Physicians - Neurology clinical subspecialties include: general neurology, stroke, epilepsy, movement disorders, neurodegenerative diseases, multiple sclerosis, neuromuscular disease, clinical neurophysiology, headache, sleep disorders, and child neurology.

UofL Physicians - Neurologys multidisciplinary staff of more than 20 clinical faculty and over 35 department members strives to provide patient-focused, world-class medical care for the entire spectrum of neurological diseases. As researchers and teachers at the University of Louisville School of Medicine, we have a passion and commitment to develop new treatments and cures for neurologic diseases. Our clinical research in stroke and multiple sclerosis are among the fastest growing programs in the country, enrolling patients in important clinical trials with potentially life-saving treatments. Our research in movement disorders, particularly in progressive supranuclear palsy and Parkinsons disease, is internationally recognized as the leading work in this subspecialty of neurology. The programs at UofL Physicians-Neurology involve a worldwide interdisciplinary network of collaboration aimed at developing preventive and corrective treatments for neurological disorders.

Find neurologists in Louisville by viewing the Our Physicians tab.

University of Louisville Physicians Child Neurology offers comprehensive diagnostic and treatment services for infants and children with disorders of the nervous system. Our specialists are devoted to promoting the optimal care and welfare of children with neurological and neurodevelopmental disorders. These disorders include epilepsy, cerebral palsy, intellectual disabilities, learning disabilities, complex metabolic diseases, nerve and muscle diseases and a host of other highly challenging conditions.

The child neurologists at UofL Physicians are specially trained physicians who have followed up their four-year medical school education training in pediatrics, general neurology, and pediatric neurology.

UofL Physicians child neurologists diagnose, treat and manage the following conditions:

For more information on Child Neurology, visithttps://www.uoflphysicians.com/child-neurology.

Correct diagnosis of neurologic disorders in older adults can be difficult because signs of disease may mimic normal signs of aging. Also, patients frequently have more than one neurologic problem at once. It can be challenging to find the best treatment once such a problem has been diagnosed.

The team of dementia professionals at the UofL Physicians Neurology practice is led by Dr. Robert Friedland, a nationally and internationally recognized expert, researcher and physician committed to identifying groundbreaking treatments that address the clinical and biological issues associated with Alzheimers and related diseases.

The practice performs an initial comprehensive evaluation, which includes a detailed history and mental status examination; standardized cognitive, functional and depression testing; pertinent neurological and physical examination; laboratory testing; neuroimaging; and referral for neuropsychological testing and for consultation by other team members as necessary. The team identifies risk factors for future cognitive decline and protective factors that may slow future cognitive decline.

Patients then receive a holistic individualized treatment plan, which aims to reduce the impact of risk factors while promoting protective factors along with neuroprotective and cognition-enhancing drugs and supplements.

Epilepsy is diagnosed in 125,000 Americans each year. Finding the experts required to address the condition can be frustrating. With epilepsy, the normal pattern of neuronal activity becomes disturbed, causing strange sensations, emotions and behavior or sometimes convulsions, muscle spasms and loss of consciousness.

Even mild seizures may require treatment because they can be dangerous during activities such as driving or swimming. Treatment which generally includes medications and sometimes surgery usually eliminates or reduces the frequency and intensity of seizures. Many children with epilepsy even outgrow the condition.

The UofL Physicians Epilepsy Center provides comprehensive diagnosis and management for people with epilepsy. Our team of specialists includes epileptologists, epilepsy fellows, neurosurgeons, neuroradiologists, nurses and EEG technologists committed to providing the best possible care for people with epilepsy. We treat the entire person taking in to consideration age, health and lifestyle to address a treatment that is the most effective for the patient. Education is the key to treating this condition, and our experts invest the time required to assist the patient and their families to fully understand the recommended treatment.

List of Services:

To learn more about the UofL Physicians Epilepsy Center, click here.

Headaches can range from minor headaches that last a few minutes to intense migraines that may be debilitating. The UofLPhysicians - Comprehensive Headache Program promotes excellence in patient care to individuals with headache and facial pain throughout the Kentuckiana region. To learn more, click here.

UofL Physicians - Parkinson's Disease and Movement Disorders, in partnership with Frazier Rehab and Neuroscience Institute, provides state-of-the art, comprehensive care to patients and families with movement disorders.

For more information, visit the UofL Physicians - Parkinson's Disease and Movement Disorders page or theUofL Medical School's Neurology page.

The University of Louisville Physicians - Neuromuscular Program provides a full complement of services ranging from clinical assessment, laboratory testing and electrodiagnosis to biopsy and histology of nerve and muscle. Currently, several clinical trials are in place for investigation of new and novel therapies of nerve, muscle and neuromuscular junction disorders.

When it comes to minimizing the effects of stroke, immediate care is vital. The University of Louisville Physicians Neurologists led two nationally recognized stroke Centers set up to make sure stroke patients receive rapid, comprehensive care; University Hospital Stroke Center and The centers offer in-house stroke team available 24 hours a day, seven days a week. Combining technology, therapy and treatment, patients receive the most comprehensive care in the region. Examination, laboratory studies, cardiac tests, and state-of-the-art imaging studies can be performed within minutes of a patient's arrival in the Emergency Care Center. A full range of medical and rehabilitation services is instantly available, from a team that includes neurologists, critical care physicians, interventional neuroradiologists, neurosurgeons, and cardiologists as well as nutritionists, physical therapists, speech-language pathologists, diabetic coordinators, and stroke nurses.

To find out more about the University of Louisville Physicians - Stroke programs, please visit UofL Hospitals Stroke Center.

View post:
Neurology | Neurology in Louisville | UofL Physicians

Northwestern Memorial Hospital | Chicago, IL …

Northwestern Memorial Hospital 251 E. Huron St. Chicago IL 60611 312.926.2000 312.926.6363 Northwestern Memorial Hospital is an academic medical center in the heart of downtown Chicago with physicians, surgeons and caregivers representing nearly every medical specialty. Northwestern Memorial enjoys a teaching and service partnership withNorthwestern University Feinberg School of Medicine, an integration that provides patients access to leading-edge clinical trials and fosters an environment of world-class patient care, academic inquiry and innovative research.

A number of world- and nationally-renowned physicians, surgeons and specialists practice at Northwestern Memorial andU.S. News & World Report ranked the hospital among the top 25 in the nation in:

The downtown medical campus includes Prentice Womens Hospital, the Feinberg Pavilion, the Galter Pavilion, the Olson Pavilion, the Arkes Family Pavilion,Lavin Family Pavilion and a number of other facilities and physician offices. The campus is designed to be a health and wellness destination and a launch pad for community involvement. In addition to providing medical services, buildings on the campus are also home to restaurants, retail stores and pharmacies that have been handpicked based on community feedback to provide both healthy and local choices. The campus also provides spaces for educational seminars, wellness classes and other events dedicated to the health of the community.

Directions and transportation

Get directions to and from Northwestern Memorial Hospital.

Transportation

Find taxis1

The Chicago Transit Authority (CTA) provides the City of Chicago and 40 neighboring communities regional transportation by bus and rail ('L' train). For specific connection information, visit the CTA website1or call 888.YOUR.CTA.1

View Metra train maps and schedules.1

Visits from family and friends can bring patients the warmth, comfort, encouragement and support they need to heal. Northwestern Medicine encourages you to spend time with your loved ones and friends during their hospital stay.

Northwestern Memorial Hospital offers several amenities, including flower and gift shops, online services, and food and beverage options, for your convenience.

Visits from family and friends can bring patients the warmth, comfort, encouragement and support they need to heal. Northwestern Medicine encourages you to spend time with your loved ones and friends during their hospital stay.

Local services are available to accommodate your needs during your visit at Northwestern Memorial Hospital.

Parking is available at discounted rates for patients and visitors of Northwestern Memorial Hospital.

Parking garage tickets must be validated each time a car is parked. Without validation, regular garage rates will apply. You can validate your ticket at the following locations.

Feinberg and Galter Pavilion: Customer service desks, first and second floors

Prentice Women's Hospital: Customer service desks, first and second floors

Lavin Family Pavilion: Customer service desks, first and second floors

Physician offices

Arkes Family Pavilion: Customer service desks, first and second floors

Download a parking map for Northwestern Memorial Hospital.

The main parking structure is located at 222 E. Huron St. (Parking A). Located between Superior and Huron streets, the public garage is across from Feinberg and Galter Pavilions. Second-floor bridges connect the garage to both pavilions.

Patients can also park at 259 E. Erie St. (Parking B) and 321 E. Ontario St. (Parking C and D) for the same discounted rate. There is a bridge connecting Parking B and C to the Feinberg Pavilion.

Parking B is located within the Lavin Family Pavilion at 259 E. Erie St.

Parking C and D are located between Erie and Ontario streets. The public garage is located on the southeast corner across from the Feinberg Pavilion.

Valet parking services2 are conveniently offered to patients and their visitors at the front entrance of the Lavin Family Pavilion and Prentice Women's Hospital. Valet rates are:

$23 for up to 7 hours

$33 for 7 to 24 hours

Visitors play an important role in helping patients recover. To maintain a healing environment and enable patients to rest, however, we ask that family and friends honor the following hours and guidelines for visits.

Daily: 9:00 am8:30 pm

To find a patient, please call our Hospital operators at 312.926.2000.

Continued here:
Northwestern Memorial Hospital | Chicago, IL ...

Neurology – SUNY Downstate Medical Center

Department Chair: Daniel M. Rosenbaum, M.D.(718) 270-2051Fax: (718) 270-3840

The Department of Neurology offers comprehensive diagnostic and therapeutic services for adults and children with disorders of the central and peripheral nervous system. Sophisticated neurophysiological evaluations, including electroencephalography, electro-myography and evoked potential testing are provided. The faculty has expertise in diverse areas such as multiple sclerosis, seizures, stroke, movement disorders, headaches and pain, infectious disease, neuromuscular diseases, peripheral neuropathies, neuro-oncology, behavioral neurology and developmental disorders. Subspecialty neuropsychological testing is also available. All of our faculty are certified by the American Board of Psychiatry and Neurology. Consultations for all neurological problems are provided on a referral basis, as well as medical management for patients with chronic neurological diseases.

Divisions:

EPILEPSYDirector: Arthur C. Grant, MD, PhD(718) 270-2959 Main Practice Location: 450 Clarkson Ave, A7-387

MEMORY AND BEHAVIORAL DISORDERS Director: Howard Crystal, MD (718) 270-6388 Main Practice Location: 450 Clarkson Ave, B6-304

MOVEMENT DISORDERS Director: Ivan Bodis-Wollner, MD, DSc (718) 270-2502Main Practice Location: 450 Clarkson Ave, Suite A

NEUROMUSCULAR DISORDERSDirector: Charles K. Abrams, MD, PhD (718) 270-2430 Main Practice Location: 450 Clarkson Ave, Suite A

PEDIATRIC NEUROLOGYDirector: Joan B. Cracco, MD (718) 270-2042 Main Practice Location: 450 Clarkson Ave, B4-330

SLEEP DISORDERSDirector: Samir Fahmy, MD(718) 252-1117 Main Practice Location: 3839 Flatlands Avenue @ Flatbush Ave.

STROKE AND CEREBROVASCULAR DISEASESDirector: Alison Baird, MD, PhD(718) 221-5188 Main Practice Location: 450 Clarkson Ave, B6-304

FOR REFERRALS CALL 1 888 270-SUNY (7869)

UNIVERSITY HOSPITAL OF BROOKLYN

Go here to read the rest:
Neurology - SUNY Downstate Medical Center

Inside the Mind of Neurologist and Author Oliver Sacks – Sarasota

The Sarasota Film Festival, March 27-April 5, typically works up to the last possible minute to finalize its line-up of movies. But we can tell you now about one headed here. Its a documentary about a unique individualthe late neurologist and author Oliver Sackstitled simply Oliver Sacks: His Own Life, by filmmaker Ric Burns (The Way West, Coney Island, and, with brother Ken, a collaborator on The Civil War series).

Burns involvement came about in a most unusual and urgent way. Sacks, famous for his exhaustive case studies into patients with mental disorders, had been diagnosed with a cancer that was going to kill him in just a few months time. He reached out to Burns, and, without doing the months of research typical before shooting, the director instead began immediately sitting down for interviews with Sacks, filming 12 hours a day, five days a week.

It was an amazing way to get a deep immersion into who Oliver was, Burns says. Here was an 81-year-old man, at a critical moment, who had just finished but not yet published a memoir about his lifes struggles. Those struggles included coming to terms late in life with his homosexuality after decades of celibacy, and working for years, often ignored, outside the traditional data-driven mindset of his scientific profession. Burns describes Sacks as this Wizard of Oz characterbearded, Jewish, avuncular, hiding his own deep wounds behind the curtain while detailing his patients lives with boundless empathy.

Oliver brought science, art and storytelling all together in such a way that you cannot tease them apart, Burns says of his subject. For an intimate glance into an amazing person, take a look at Burns film this month.

More info: sarasotafilmfestival.com

Here is the original post:
Inside the Mind of Neurologist and Author Oliver Sacks - Sarasota

COVID-19: AAN Urges Feds to Further Expand Telehealth Benefits – Medscape

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

In the face of the COVID-19 pandemic, the American Academy of Neurology (AAN) is calling on the federal government to do more to expand telehealth services beyond Medicare.

As reported by Medscape Medical News, last week the Trump administration announced an expansion of telehealth benefits to help stop the spread of COVID-19 and allow more Medicare patients to receive virtual care without having to visit a healthcare center or physician office.

Under the expansion, Medicare will pay for office, hospital, and other visits furnished via telehealth across the country and including in the patient's home, delivered by a range of providers, such as physicians, nurse practitioners, clinical psychologists, and licensed clinical social workers.

Prior to this waiver, Medicare would only pay for telehealth on a limited basis, such as when the patient receiving the service was in a designated rural area.

However, in a letter to Alex Azar, Secretary of the US Department of Health & Human Services (HHS), the AAN says the easing of restrictions on telehealth should be extended beyond Medicare fee-for-service to both Medicare Advantage and Medicaid patients.

"It is very heartening that the government is stepping up to the plate" and lifting many telemedicine restrictions, Neil Busis, MD, member of the AAN Health Policy Subcommittee, told Medscape Medical News.

Busis, who leads the telemedicine program for the department of neurology at NYU Langone Health in New York City, said the global pandemic has "heightened, focused, and sharpened" attention to the need for telehealth services, particularly for neurology.

"By definition, a lot of neurology patients have mobility problems, traveling is a burden, making it difficult to see a neurologist," he said.

Busis hopes these waivers in telehealth, made on a temporary and emergency basis, will become permanent once the COVID-19 pandemic has passed.

"What we hope is that the usefulness of various virtual technologies tested in the crucible of this pandemic will stimulate people to think about it once the pandemic is over and not rescind these loosening of restrictions, and that this will be the beginning of a new era for telemedicine," he said.

The COVID-19 pandemic may be a "catalyst to accelerate the incorporation of non-face-to-face care into our armamentarium," he added.

"What we have discovered in recent years is non-face-to-face care with enabling communication technologies is as effective in many clinical situations as face-to-face care. Now is the time to really focus on making the virtual experience as good as possible and to make it as available to as many people as possible," said Busis.

The AAN also calls on the federal government to urge states to take action to ensure access to telehealth services and allow telehealth companies to provide telehealth technology and education free of charge to providers who don't currently use telehealth in their practices.

"The AAN notes that doing so may implicate provisions of the Anti-Kickback Statute. We believe during the current emergency that HHS should issue guidance making it clear to providers that accepting free access to telehealth platforms and education does not put them at risk of violating fraud and abuse laws," the letter signed by AAN President James Stevens, MD, states.

The AAN also wants the government to reduce regulatory burdens during this public health emergency to allow physicians more time to focus on patient care. "This is especially true for providers that are self-quarantining or are in a practice that is experiencing staffing shortages due to self-quarantines," he writes.

Specifically, the AAN asked the Centers for Medicare & Medicaid Services (CMS) to extend the March 31 deadline for physicians to submit their data for the Merit-based Incentive Payment System program for calendar year 2019 (and other compliance deadlines) by at least 30 days.

The AAN also calls on CMS to delay implementation of the Appropriate Use Criteria program by 1 year, saying that many providers will not have the capacity to "meaningfully" participate in the current testing year for the program.

For more Medscape Neurology news, join us on Facebook and Twitter.

Go here to see the original:
COVID-19: AAN Urges Feds to Further Expand Telehealth Benefits - Medscape

Epilepsy is one of the commonest conditions affecting the brain – Gulf News

Dr Sulaiman Al Habib Hospital Image Credit: Supplied Highlight

Dr Mohamed Osman Eltahir Babiker, Consultant Paediatric Neurology, Dr Sulaiman Al Habib Hospital, talks about how properly diagnosing epilepsy in children is the most important step towards treatment

What are the types of patients you see as a paediatric neurologist?

Paediatric neurology is a sub-specialty branch in paediatrics and child health that essentially covers medical conditions that affect the brain, spine, nerves and muscles of children from the first day of life up to the age of 16. Common conditions that a paediatric neurologist sees, diagnoses and treats include epilepsy, headaches, cerebral palsy, developmental delay, disorders of movement, muscle weakness and nerve problems to name a few.

What is epilepsy and what are epileptic seizures?

Epilepsy is derived from a Greek word that literally means a state of being overcome, seized or attacked. Interestingly, the Arabic word al saraa is translated in English as to be knocked down, which reflects the ancient name the falling sickness, so called because the patient suddenly falls to the ground during a fit. Epilepsy is one of the commonest conditions affecting the brain.

- Dr Mohamed Osman Eltahir Babiker, Consultant Paediatric Neurology, Dr Sulaiman Al Habib Hospital

There are billions of cells on the brains surface and these cells communicate with each other by sending tiny electrical currents at very calculated levels to execute the different body functions such as raising an arm, talking and walking. An epileptic seizure occurs when a localised area in the brain or the brain in its entirety is dominated by an out-of-control burst of this electrical activity.

There are different types of seizures depending on where in the brain this aberrant electrical activity is coming from. Epilepsy is the individuals tendency to have recurrent epileptic seizures.

How do you diagnose epilepsy in children?

Properly diagnosing epilepsy in children is perhaps the most important first step towards the best possible treatment outcomes. Many conditions in children may present in a manner similar to epileptic seizures. Hence, it is paramount that we take adequate history that describes the episodes in question in as much detail. Nowadays, almost everyone has a mobile phone with a camera. Taking videos of the episodes as they happen can prove very helpful when they are reviewed by the neurologists. The next step is to perform a test called electroencephalogram (EEG for short), which involves application of wires over the head to record the patterns of the brains electrical waves and circuits.

The EEG can be run for about an hour or so but sometimes we may need to extend the recording for 24 hours or even longer to gain more information. The EEG usually serves to give supporting evidence before we can confidently diagnose epilepsy but it can also give valuable information about the type of epilepsy the child has.

Epilepsy can result from a wide range of causes and that is why other tests might be needed to understand why the child has developed epilepsy. These may include brain imaging via magnetic resonance imaging, or MRI. Nowadays we are relying on genetic testing more and more. It is worth pointing that it is not always feasible to find a direct cause for the childs epilepsy despite our best efforts.

What are the treatment options for patients with epilepsy?

There are three main levels of treatment. These are medications, brain surgery and the ketogenic diet. Often, we start with an anti-epileptic medication that has been appropriately chosen based on the childs characteristics and the type of epilepsy he or she has. A balance has to be struck between the effectiveness of the medicine and its side effects. In children, we tend to start with smaller doses then build them up slowly over time to ensure safety and tolerability.

Up to 70 per cent of patients respond well to one or two medications and we will be able to successfully withdraw the medicine within a couple of years. In cases whereby medications do not work satisfactorily or when there is a diseased part of the brain, the surgical option is then considered. There are different surgical options and these are chosen after careful consideration and planning on a case-by-case basis.

Does a ketogenic diet help in epilepsy?

The role of the ketogenic diet in epilepsy treatment has been recognised for nearly a century now. Essentially, it is a strict type of diet that consists of low-carbohydrate, high-fat and calculated protein content. In the face of low carbohydrate and sugar intake, the body is forced into producing chemicals known as ketones that the brain uses as its main source of energy. This is thought to be the mechanism through which the ketogenic diet works although this does not seem to be the whole story thus far.

In cases where medication or brain surgery do not seem to fully control the epileptic seizures, the ketogenic diet may be a reasonable option. We know from research that the chance of response can be as high as one in three. It must be remembered that the selection for and administration of the ketogenic diet should be under strict medical supervision. This is because this type of diet can potentially cause problems such as low blood sugar levels, tummy upset, kidney stones, poor body growth and so forth.

What is the hardest part of being a paediatric neurologist and what are the challenges of looking after children with neurological problems?

Paediatric neurology is such an intellectually stimulating branch of medicine. Many of the conditions we deal with are rare and, needless to say, serious. Most share similar symptoms and some require time, patience and sometimes a lot of detective work before they are diagnosed. Given that several neurological problems may last for a long time, paediatric neurologists are privileged to have the opportunity of establishing long-term trusting relationships with the children and their families. Transparent, honest and responsive communication with the families all the way through is the foundation of these relationships. Although many of the conditions we see and manage have no cure because of their very nature, the satisfaction for us comes from the mere fact that we can always care!

View original post here:
Epilepsy is one of the commonest conditions affecting the brain - Gulf News

Brain Amyloid Deposition and Intracranial Atherosclerotic Disease in Adults – Neurology Advisor

There is no evidence for an association between cerebral -amyloid deposition, a marker of Alzheimer disease, and intracranial atherosclerotic plaque or stenosis, according to study results published in JAMA Neurology.

Although previous studies have shown that intracranial atherosclerotic disease (ICAD) is a significant risk factor for stroke and may increase the risk for all-cause dementia, limited data are available on the association between ICAD in adults without dementia and cerebral -amyloid deposition.

The cross-sectional study included data on dementia-free adults aged 70-90 years from the Atherosclerosis Risk in Communities-Positron Emission Tomography (ARIC-PET) study that completed florbetapir PET scans and magnetic resonance imaging high-resolution vessel wall imaging. The main outcome was the global cortical standardized uptake value ratio (SUVR), as a scan was considered positive for -amyloid if the global cortical SUVR was >1.2 on florbetapir PET.

The study cohort included 300 patients (mean age 76 years, 56% women) with available imaging data, of whom 105 participants (35%) had evidence for ICAD of any vessel. Mean SUVR was higher in participants with intracranial plaques compared with participants without plaques (1.340.29 vs 1.270.23, respectively; P =.03). In adjusted models, there was no statistically significant association between the presence of any plaque (adjusted odds ratio [OR] 1.20, 95% CI, 0.69-2.07), number of plaques (adjusted OR 1.10, 95% CI, 0.96-1.26), or plaque location (anterior circulation, adjusted OR 1.15, 95% CI, 0.61-2.16; posterior circulation, adjusted OR 1.27, 95% CI, 0.69-2.36) with elevated SUVR.

Similarly, there was no significant association between any measurable stenosis (adjusted OR 1.27, 95% CI, 0.71-2.27), a stenosis of >50% (adjusted OR 2.33, 95% CI, 0.82-6.60), or a stenosis of >70% (adjusted OR 2.35, 95% CI, 0.19-29.48) with elevated brain -amyloid.

The study had several limitations, according to the researchers, including the cross-sectional nature, single measurement of -amyloid deposition, exclusion of patients with dementia, and inability to fully adjust for potential confounders.

We found no evidence of an association between plaque presence and global cerebral -amyloid in individuals without dementia broadly, concluded the researchers.

Reference

Gottesman RF, Mosley TH, Knopman DS, et al. Association of intracranial atherosclerotic disease with brain -amyloid deposition: secondary analysis of the ARIC study [published online ahead of print, 2019 Dec 20]. JAMA Neurol. doi: 10.1001/jamaneurol.2019.4339

Read more:
Brain Amyloid Deposition and Intracranial Atherosclerotic Disease in Adults - Neurology Advisor

Neurology | Neurology conferences | Neuro congress …

Advanced Neurology 2020

We are extremely gratified to declare our upcoming fortuitous neurology conference 4th World Congress on Neurology and TherapeuticsConference is scheduled during May 08-09, 2020 at Prague, Czech Republic.

It is our boundless privilege to solicit each one of you to our meritorious neuro meet of all the dignitaries worldwide over there. We believe in serving people with the most advanced solutions to Neurological Impairments where we stood prior in our last event 3rd World Congress on Neurology and Therapeutics Conference in Madrid, Spain. It was a tremendous success over the year to establish a strong affinity with our advanced neurological solutions, diagnosis and NeurotherapeuticsConference.

View our Past Conference Report of Advanced Neurology 2019 at https://neurology.pulsusconference.com/2019

Our propitious neurology congress is tailored around the theme Know the Unknown Advanced Solutions on Neurology

Weve constructed this years neurology conference primarily based on input from you, so get equipped for a streamlined agenda packed with neurologists, neurosurgeons, neuro specialists, neuro freaks, neuro physicians, industry insights, innovations, and masses of opportunities to share ideas and provide remarks.

Would like to give a glimpse of whats in:

Drop a line or note! it is all really worth to know from us.. neuromeet@pulsusgathering.com

Sincerely

Executive Director

Session on Neurology

The observe of neurons that is the functional unit of mind worries with the brains normal functioning, neural disorders, neural diagnosis and neurology treatment which incorporates each aspect about the condition of the ailment in our neurology conference. This place of interest offers with the backbone, the fearful gadget such as its masking, blood vessels, afferent and efferent tissues is thought to be neurology. A physician who specializes in neurology is known as a neurologist. The top neurologists treats troubles which have an effect at the brain, spinal cord, and nerves, which incorporates Cerebrovascular treatment, Spinal disorders and neurological disordersin various sessions of neurology conference.

Related Neurology Conferences | Neurology Conference | World Neurology Congress | Advanced Neurology Congress | Neurology meetings | Europe Neurology Conferences

Related Society & Associations Socit Franaise de Neurologie ; Croatian Neurological Society ; Finnish Neurological Association ; Cyprus Neurological Society ; Estonian Society of Neurologists & Neurosurgeons ; Czech Society of Neurology ; Danish Neurological Society ; Bulgarian Society of Neurology ; Albanian Society of Neurology ; Belgian Neurological Society ; Association of Azerbaijan Neurologists and Medical Geneticists ; Armenian Association of Neurologists

Session on Neurogenesis

The process of formation of the neuron cells from the predefined cells to the grownup neurogenesis is described as Neurogenesis. This mechanism takes area throughout embryogenesis by using the neural stem cells and progenitor cellsin our neurology conference. This mainly deals with the form and features of diverse varieties of science in neurology. via a chain of genetic mechanisms of mobile fate dedication, many unique types of excitatory and inhibitory neurons are made from exceptional kinds of neural stem cellsin every session of neurology conference. The boom method in area and evolution of practical matter. Our neurology conference moreover describes about the biophysical parameters of highbrow capability and new techniques for the development of neural cells in distinctive way of life medium.

Related Neurogenesis Conferences | Neurogenesis Congress | Neurogenetic meetings | Gliogenesis Conferences | Adult Neurogenesis Conference | Neurobiology Conference| Neurology Conference

Related Society & Associations Hellenic Association of Neurology ; Latvian Neurologists Association ; Hungarian Society of Neurology and Psychiatry ; Icelandic Neurological Society ; Societ Italiana di Neurologia ; Irish Institute of Clinical Neuroscience ; Norwegian Neurological Association ; Association of British Neurologists ; Turkish Neurological Society ; Polish Neurological Society ; Socit Suisse de Neurologie (Schweizerische Neurologische Gesellschaft) ; Portuguese Society of Neurology (Sociedade Portuguesa de Neurologia) ; Romanian Neurological Society ; All-Russian Society of Neurologists ; Yugoslav Neurological Society ; Slovenian Society of Neurology ; Sociedad Espaola de Neurologia ; Swedish Neurological Society (Svenska Neurologforeningen)

Session on Neurophysiology

The take a look at of nature and foundation of the brain which additionally issues with the functioning of the nervous system, frequently the use of the neurophysiological or molecular organic system that is the subspecialty of both the frame shape and Neuroscience as awesome regions of brain represent indicators to distinct elements of the body in neurology conference. This concern is counted need to deliver an extraordinary description of the revolutionized anatomy of the nervous system, the motor reaction manipulates neurons, perception processing, and reminiscence neurons. Neurology conferences discussions also can be made in neuromuscular physiology, neural mechanisms of higher nerve interest and troubles of Neuroscience also may be conferred in every session of neurology conference.

Related Neurophysiology Conferences | Neurophysiology Congress | Clinical Neurophysiology Conferences | Didactics Conferences | Neuroscience Conference | Prague Neurology events| Neurology Conferences

Related Society & Associations International Federation of Clinical Neurophysiology: IFCN ; American Clinical Neurophysiology Society ; The British Society for Clinical Neurophysiology ; Canadian Society of Clinical Neurophysiologists ; American Clinical Neurophysiology Society ; German Society for Clinical Neurophysiology and Functional Imaging (DGKN) ; The Italian Clinical Neurophysiology Society ; International Society of Intraoperative Neurophysiology (ISIN) ; Malaysian Society of Neuroscience (MSN) ; Clinical Neurophysiology Society of South Africa

Session on Clinical Neurology

Our series of neurology conferences deals with the sicknesses of the central nervous system consist of some of the most disabling situations, such as multiple sclerosis (MS), stroke, motor neuron disorder (MND), Alzheimers, Huntingtons and Parkinsons sickness like various other sub category in neurology conference. Those neurological disorders have been the threat to all the people who really strive to eradicate it and establish a healthy aging process and healthy environment for their circle of relatives and carers, and to society as an entire from this neurology conferences. We need to understand underlying neurological treatment with a purpose to treat these situations successfully. Neurology congress provides an appropriate setting to percentage facilities, know-how and as well as realise our purpose of making use of our studying in medical exercise

Related Clinical Neurology Conferences | Clinical Neurology Congress | Medical Neurology Conferences | Neurologists Conference | Neurological Sciences Conferences | Neuroscience Congress| Neurology Conference

Related Society & Associations Association of University Professors of Neurology ; Child Neurology Society ; Congress of Neurological Surgeons ; American Association of Neurological Surgeons ; American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) ; American Association of Neuropathologists ; American Association of Neuroscience Nurses ; American Brain Foundation ; American Epilepsy Society ; American Society for Experimental Neuro Therapeutics (ASENT) ; American Society for Neural Transplantation & Repair ; American Society for Neurochemistry ; American Society of Neuroimaging ; American Society of Neuroradiology ; American Society of Neurorehabilitation

Session on Neurological Nursing

Neuroscience nurses a very challenging nursing science contend with humans with diffusion of neurological conditions and issues throughout the lifespan and dealing with all health care settings amidst neurology conferences. The purpose of neurology events is to realize the nursing opportunities which have the ability to maximize consequences to prevent, to take care of the people with excessive neurological disorders. there are numerous neuro conferences specialities of encompassed internal this subject of practice collectively with (however now not constrained to) the subsequent: geriatric nursing, neurosurgery, neurotrauma, Neuroscience critical care, prolonged-time period neurological disorders, Parkinsons sickness, epilepsy, existence-limiting neurological disorders in our world neuro congress, e.g. motor neurone disorder, Huntingdons ailment especially in neurology pulsus conference.

Related Neurological Nursing Conferences | Neuroscience Nurse Conference | Neuro-nursing Congress | Neurosurgery nursing Conference | Nursing Conference Europe| Neurology Conferences

Related Society & Associations American Association of Neuroscience Nurses ; Association of Child Neurology Nurses ; British Association of Neuroscience Nurses (BANN) ; Canadian Association of Neuroscience Nurses ; Epilepsy Nurses Association ; East Coast Community Healthcare's Neurological Nursing Service ; Movement Disorder Society ; Association of University Professors of Neurology ; Child Neurology Society ; Congress of Neurological Surgeons ; International Brain Injury Association ; International Neuromodulation Society ; International Parkinson and Movement Disorder Society

Session on Neuropediatric

Neuropediatric is the branch of medication handling mental health, neurological disorders of children. The concern of Paediatric Neurology, additionally called Paediatric Neurology, encompasses issues of the brain, spinal twine, peripheral nerve and muscle affecting babies, youngsters and younger human beings in our neurology conference. The form of patients seen through paediatric neurologists varies from people with common, pretty sincere conditions, inclusive of cerebral palsy or migraine. This robust world neurology congress type of situation lets in Paediatric Neurologists to shape their medical or clinical careers in line with their scientific or studies pursuits from our neurology conferences. Paediatric neurogenetic issues are sicknesses of the mind, spinal cord, nerves and muscle tissues which can be resulting from modifications in genes or chromosomes. There are loads of neurogenetic disorders that could be discovered in every one among kind methods in every aspects of neurology conference.

Related Neurology Conferences | Neuro Paediatric Congress | Paediatric Neurology Congress | Nordic Neuropediatric Conference | Paediatric Neurology Conferences | Neurology Conferences Europe| Neurology Conferences

Related Society & Associations European Paediatric Neurology Society (EPNS) ; Child Neurology Society ; British Paediatric Neurology Association ; The Canadian Association Of Child Neurology ; Belgian Society of Pediatric Neurology ; American Society of Pediatric Neuroradiology ; International Society of Neuroimmunology ; Japanese Society for Neuroimmunology ; Italian Association of NeuroImmunology ; Indian Immunology Society ; International Society of Neuroimmunology ; Pediatric Society of Neuro-oncology ; German Neuropediatric Society ; Nordic Neuropediatric Society ; Scandinavian Neuropediatric Society

Session on Neuroimmunology

Neuroimmunology is an area of neuroscience, combining the immune system and the nervous systemin neurology conferences. The immune system administers defence in competition to those organisms, inefficiency of the equal consequences in Infections. Neuro Infections have been set up to sell outstanding affected individual care and research for immune and infectious issues of the apprehensive device through training of clinical and simple generation researchers, growing and offering diagnostic services, consultation services and supporting develop new modes of remedy from our keynotic presentations of neurology conference. Collectively our neurology conference offer understanding in several major immune and infectious disorders of the anxious system, consisting of Neuro-AIDS and other viral and opportunistic infections, poisonous Leuko-encephalopathies, Transverse myelitis and other myelopathies, GuillainBarr syndrome, persistent demyelinating polyneuropathy, Myasthenia gravis and different immune-mediated problems of the peripheral nervous systemeven more recent conditions from neurology conference.

Related Neuroimmunology Conferences | Neuroimmunology Congress | Neurology Events | Neuro infection Conference | Neurological Disorders Conference | Neurology Prague Events| Neurology Conferences

Related Society & Associations Austrian Society of Neurology (sterreichische Gesellschaft fr Neurologie) ; Georgian Society of Neurologists ; Socit Luxembourgeoise de Neurologie asbl ; Deutschen Gesellschaft fr Neurologie ; Lithuanian Neurological Society ; British Society For Clinical Neurophysiology ; The Physiological Society ; Neurological Sciences and Neurophysiology ; The International Neuropsychological Society ; British Peripheral Nerve Society ; International Society for Autism Research ; National Neurotrauma Society ; North American Spine Society ; Peripheral Nerve Society ; United Council for Neurologic Subspecialties

Session on Neuroplasticity

Neuroplasticity is also known as brain plasticity and neural plasticity that encompasses the 2 synaptic and non-synaptic plasticity and it refers to improve in neural pathways and synapses due to difference in behaviour, surroundings, neural strategies, wondering, and feelings similarly to changes due to physical are discussed in neurology conference. The goal of our neurology congress is to understand the brain plasticity advances in neurite transforming and the way to increase neural connections. Neurorehabilitation is a medical approach which goals to beneficial aid recovery from nervous system damage and to lessen or make amends for any practical alterations because of it.

Related Neuroplasticity Conferences | Cerebral Palsy Congress | Neuromodulation Conferences | Neurorehabilitation Conferences | Neurosciences Conferences Prague | Neurology Congress 2020| Neurology Conference

Related Society & Associations Socit Franaise de Neurologie ; Croatian Neurological Society ; Finnish Neurological Association ; Cyprus Neurological Society ; Estonian Society of Neurologists & Neurosurgeons ; Czech Society of Neurology ; Danish Neurological Society ; Bulgarian Society of Neurology ; Albanian Society of Neurology ; Belgian Neurological Society ; Association of Azerbaijan Neurologists and Medical Geneticists ; Armenian Association of Neurologists

Session on Neural Circuits ; Neural feedback

Neurofeedback (NFB), also called Neurotherapy, neurofeedback or EEG biofeedback is a form of biofeedback that makes use of actual-time shows of electroencephalography to demonstrate brain activity, frequently with an intention of controlling significant nervous system activity in our neurology conference. Through monitoring brain activity, its possible to teach our brain to provide specific cognitive function that can aid relaxation, help us be more inexperienced in our each day obligations, or offer non-pharmaceutical treatment for plenty conditions and issues is the vital role of neurology conference. Our neurologists, neuro conference participants are also neurofeedback practitioners and researchers who are pushed to promote excellence in scientific exercise, educational applications, and research in applied neuroscience to be able to better apprehend and enhance brain mechanism. Biofeedback therapy: uses and benefits: types, motive and dangers, Biofeedback device/devices, development of Biofeedback remedy, situations dealt with the usage of Biofeedback.

Related Neural Circuits Conference | Neurology Congress | Neurosurgery Congress Europe | Neurosurgeons Conference | Neuromodulation Conferences | Brain Behavior Conference| Neurology Conferences

Related Society and Associations International Society for Neurofeedback & Research ; The Association for Applied Psychophysiology and Biofeedback (AAPB); Western Association of Biofeedback and Neuroscience ; Society of Applied Neuroscience ; Applied Neuroscience society of Australasia (ANSA); Neurofeedback Society of UTSA ; Northeast Region Biofeedback Society (NRBS) ; Cognitive Neuroscience Society ; Mid-Atlantic Biofeedback Society ; International Society for Neuronal Regulation ; Mexican Society for Biofeedback and Neurofeedback (SMBN) ; Brandywine Valley Counselling and Neurofeedback Center ; The Biofeedback Society of Florida ; Autism Society Inland Empire ; Spanish Society of Bio and Neurofeedback (Sebine) ; Center for Academic and Psychological Services ; Autism Society Philippines ; Alpha Brain-Wave Neurofeedback Training ; Body Mind and Brain Neurotherapy Gold Coast

Session on Neurostimulation

The sector of Neurostimulation is present process notable increase, neuro activity stimulation strategies are suddenly reworking studies into brain mechanisms, from the molecular to the behavioral, and provide new strategies to therapeutics for neuro disorders. in lots of processes, the sector of brain stimulation represents a paradigm shift, augmenting and on occasion replacing the prominent psychopharmacological techniques of the beyond several a long time. Cognitive neuroscientists will mingle with neurosurgeons and brain modelling physicists. Neurology conference pass-disciplinary meeting will also offer the opportunity to have interaction with founders and luminaries within the neurology area.

Related Neurostimulation Conferences | Neurostimulation Congress | Neurostimulation Conference Carolina | Neurotransmission events | Neurology Conference Czech Republic | Neurology 2020

Related Society and Associations International Neuromodulation Society (INS) ; International Society for ECT and Neurostimulation (ISEN) ; Brazilian Medical Association ; Association of Pallidal Neurostimulation ; American Association for the Advancement of Science ; Neurological Societies Task Force on neurostimulation for pain ; Neuromodulation - Interstitial Cystitis Association ; Anxiety and Depression Association of America (ADAA)

Session on Neurotherapeutics ; Neuropharmacology

It's miles an older time period for the remedy of neurological disorders which have an impact on the brain mechanism and the nervous system which can be treated with certain therapeutic modalities and novel research that is ongoing in research activity. Neurotherapeutics session almost covers half of the world's advanced solutions for the neurological impairments, neurological disorders and what not to be added. There can be a profound boon within the gathering of our world neuro congress where diagnostics technique and drug discovery inside the area of Neurology and various allied sciences under neurology can be discussed. It consists of Stem cells and remedy, Nerve damage and restore clinical Case document, Neurogenesis, cell and gene-primarily based method and Neurotransmitter release and cell restore.

Related Neurotherapeutics Conference | Advanced Neurology Conference | Neurotherapeutic Symposium | Experimental Neurotherapeutics Conference | Neurology Conferences 2020

Related Society and Associations American Society for Pharmacology and Experimental Therapeutics (ASPET) ; Society on NeuroImmune Pharmacology ; Canadian Society of Pharmacology and Therapeutics (CSPT) ; Indian Pharmacological Society ; Japanese Society of Neuropsychopharmacology ; Australasian Society of Clinical and Experimental Pharmacologists ; International Union of Basic and Clinical Pharmacology (IUPHAR) ; International Behavioral Neuroscience Society ; American Society of Clinical Psychopharmacology (ASCP) ; Argentinean Society of Experimental Pharmacology ; American Society for Experimental Neurotherapeutics (ASENT)

Session on Neurological disorders ; Neurodegenerative disorders

Neurodegenerative disorders cause your mind and nerves to deteriorate through the years. They may be able to alternate your personality and reason confusion. They also can ruin your minds tissue and nerves. A few neuro disorders, such as Alzheimers disease, Parkinson's, Huntington's might, Dementia... also increase as you age. They may slowly impair your memory and idea strategies. Other neurological diseases, which incorporates Tay-Sachs ailment, are genetic and start at an early age. A neurological disorder is any turmoil inside the nervous system fundamental, biochemical or electrical irregularities inside the thoughts, spinal line or different nerves can bring about the neurology scope of manifestations. Neurology conferences relates all the cases of neurological manifestations incorporate lack of motion, muscle shortcoming, awful coordination, and lack of sensation, seizures, perplexity, torment and adjusted levels of awareness.

Related Neurological disorder Conference | Brain Disorder Conference | Neurology Conferences | Brain Disorder Conferences | Neurodegenerative Conferences |Neurology Meetings 2020

Related Society and AssociationsInternational Society for Neurofeedback & Research;The Association for Applied Psychophysiology and Biofeedback(AAPB);Western Association of Biofeedback and Neuroscience;Society of Applied Neuroscience;Applied Neuroscience society of Australasia(ANSA);Neurofeedback Society of UTSA;Northeast Region Biofeedback Society(NRBS) ;Cognitive Neuroscience Society;Mid-Atlantic Biofeedback Society;International Society for Neuronal Regulation;Mexican Society for Biofeedback and Neurofeedback(SMBN) ;Brandywine Valley Counselling and Neurofeedback Center;The Biofeedback Society of Florida;Autism Society Inland Empire;Spanish Society of Bio and Neurofeedback(Sebine) ;Center for Academic and Psychological Services;Autism Society Philippines;Alpha Brain-Wave Neurofeedback Training;Body Mind and Brain Neurotherapy Gold Coast

Session on Neuromuscular Disorders

Neuromuscular disorders are the illnesses which impair the functioning of muscle groups each right now via affecting the voluntary muscle groups or with the resource of affecting the nerves system or neuromuscular junctions. revolutionary muscle weak factor is the condition in those neurological disorders. Neuromuscular disorders may be labelled as ailments of the Neuromuscular disorders, neuron cellular problems, Motor neuron disorder and so on. so as to diagnose these sicknesses, Electromyography should be used, inside the route of Electromyography, small electric impulses are given to the nerves and electric responses are recorded. This allows discovering the lack of nerve fibres and problems of insulation of nerves. Neuromuscular conference allows to interpret in these criterias all along the neurology conference in Prague.

Related Neuromuscular Disorder Conferences | Annual Neurology Congress | Neuromuscular Conferences | Neurology Conferences | Neurology 2020 Europe Conferences

Related Society & Associations Hellenic Association of Neurology ; Latvian Neurologists Association ; Hungarian Society of Neurology and Psychiatry ; Icelandic Neurological Society ; Societ Italiana di Neurologia ; Irish Institute of Clinical Neuroscience ; Norwegian Neurological Association ; Association of British Neurologists ; Turkish Neurological Society ; Polish Neurological Society ; Socit Suisse de Neurologie (Schweizerische Neurologische Gesellschaft) ; Portuguese Society of Neurology (Sociedade Portuguesa de Neurologia) ; Romanian Neurological Society ; All-Russian Society of Neurologists ; Yugoslav Neurological Society ; Slovenian Society of Neurology ; Sociedad Espaola de Neurologia ; Swedish Neurological Society (Svenska Neurologforeningen)

Session on Neurosurgery

Medical and Surgical examination which offers with the treatment of neurological problems, neural disorders, blood clots, and many other specific neurology issues related to the brain, spinal cord, peripheral nerves, central nervous and in addition operating the cranial cerebrovascular system is coined to Neurosurgery. Emergencies like intracranial haemorrhage and neurotrauma are essentially involved in most of the neurosurgery. some of the scientific sessions of neurosurgery conference includes vascular neurosurgery and endovascular neurosurgery, stereotactic neurosurgery, beneficial neurosurgery, and epilepsy surgery, mind tumor, oncological neurosurgery, skull base surgical treatment, spinal neurosurgery, peripheral nerve surgical operation. Neurosurgery is a whole-time dedication to treating patients with neurological disorders and to the search for better therapies, cures and investigates the most promising advances in neuroscience research, and train tomorrow's leaders in neurosurgery.

Related Neurosurgery Conference | Neurosurgery Conferences | Neurosurgeons gathering | World Neuro Congress |Neurology Congress 2020 | Neurology Prague conferences

Related Society & Associations International Federation of Clinical Neurophysiology: IFCN ; American Clinical Neurophysiology Society ; The British Society for Clinical Neurophysiology ; Canadian Society of Clinical Neurophysiologists ; American Clinical Neurophysiology Society ; German Society for Clinical Neurophysiology and Functional Imaging (DGKN) ; The Italian Clinical Neurophysiology Society ; International Society of Intraoperative Neurophysiology (ISIN) ; Malaysian Society of Neuroscience (MSN) ; Clinical Neurophysiology Society of South Africa

Session on Neuroimaging ; Radiology

Neuroradiology performs a vital position inside the prognosis and characterization of various Neurological disorders. Neurology conferences entails amazing sorts of Imaging studies collectively with Computed Tomography (CT) and Magnetic Resonance Imaging (MRI). simple Radiography and Ultrasound are used in a confined foundation especially in Pediatric population. Neuroimaging is the mapping of the human mind the usage of purposeful Magnetic Resonance Imaging (fMRI). Neuroimaging determines the association among brain mechanism elements and health influence on mind growing older at some level within the person lifespan. Neuroimaging determines how difference and trade-in Cerebral structure, complexly relates to behaviour and Cognition at a couple of levels of analysis. Neurology Conference brings collectively various topics of interests consisting of practical Neuroimaging, Cognitive Neuroscience, and Cognitive mechanism models.

Related Neuroimaging Conferences | Neuroimaging Congress | Neuroradiology meetings | Neurology Conferences | Neurology Congress | Advanced Neurology Conferences |Neurology 2020

Related Society & Associations Association of University Professors of Neurology ; Child Neurology Society ; Congress of Neurological Surgeons ; American Association of Neurological Surgeons ; American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) ; American Association of Neuropathologists ; American Association of Neuroscience Nurses ; American Brain Foundation ; American Epilepsy Society ; American Society for Experimental Neuro Therapeutics (ASENT) ; American Society for Neural Transplantation & Repair ; American Society for Neurochemistry ; American Society of Neuroimaging ; American Society of Neuroradiology ; American Society of Neurorehabilitation

Session on Psychology ; Psychiatry

Exploration of neurology or all of those questions has been and is being undertaken in such disciplines as cognitive psychology, neuro linguistics, philosophy, artificial intelligence, robotics, neuroscience, training, cognitive sciences, behavioural economics, and others. The fundamentals and the minor in Cognitive science, neurology conferences consequently, constitute a proper means of bringing collectively students and neuro physicians in exclusive disciplines who percentage common interests. From our neurology conference, we are seeking to enhance the view supplied by way of every person discipline through exploration or the methodologies of Neurology. Interdisciplinary group of psychiatrists, clinical psychologists, forensic psychologists, neuropsychologists, occupational psychologists and health psychologists based within the Institute of Mental Health and enjoying close links with topics related to the neurosciences and the behavioural sciences.

Related Psychology Conferences | Psychology Congress | Psychiatry Conferences | Psychiatry Meetings | Psychiatry Conferences | Neurology Conferences

Related Society & Associations American Association of Neuroscience Nurses ; Association of Child Neurology Nurses ; British Association of Neuroscience Nurses (BANN) ; Canadian Association of Neuroscience Nurses ; Epilepsy Nurses Association ; East Coast Community Healthcare's Neurological Nursing Service ; Movement Disorder Society ; Association of University Professors of Neurology ; Child Neurology Society ; Congress of Neurological Surgeons ; International Brain Injury Association ; International Neuromodulation Society ; International Parkinson and Movement Disorder Society

Session on Behavioural Sciences

The study of the relationship between behavior, emotion, and cognition on the one hand, and brain feature on the other. Neuropsychology research the shape and characteristic of the mind as they relate to unique mental strategies and behaviours. medical neuropsychology is a uniqueness in professional psychology that applies standards of evaluation and intervention primarily based upon the medical look at human behavior because it pertains to normal and unusual functioning of the relevant nervous system. The robust factor of neurology congress is dedicated to improving the of brainbehaviour relationships and the software program of such understanding to human troubles.

Related Behavioral Science Conferences | Behavioral Neuroscience Conferences | Cognitive Sciences | Cognitive Neuroscience Conferences | Cognitive Conferences | Behavioral Neurology Conferences

Related Society & Associations European Paediatric Neurology Society (EPNS) ; Child Neurology Society ; British Paediatric Neurology Association ; The Canadian Association Of Child Neurology ; Belgian Society of Pediatric Neurology ; American Society of Pediatric Neuroradiology ; International Society of Neuroimmunology ; Japanese Society for Neuroimmunology ; Italian Association of NeuroImmunology ; Indian Immunology Society ; International Society of Neuroimmunology ; Pediatric Society of Neuro-oncology ; German Neuropediatric Society ; Nordic Neuropediatric Society ; Scandinavian Neuropediatric Society

Session on Clinical trials, case studies and recent researches

The Web Directory

Best Advertising Platform, Discover Fantastic Sites, Excellent Online Advertising, Best Web-based Marketing, Market Your Websites Online

Nctweb Web Directory

TargetsViews Free Links Web Directory

web directory

Picktu Directory

TargetsViews Free Links Web Directory

LinkPedia Web Directory

Interesting Dir

With utmost appreciation, Advanced Neurology 2019 thanks all the participants for their sincere efforts to place our 3rd World Congress on Neurology and Therapeutics, October 07-08, 2019 in Madrid, Spain a successful and memorable one.

In a row of series, Pulsus Group has completed over three international Neurology conferences. We would really like to thank all of our outstanding dignitaries of world neuro congress for presenting us with the splendid keynotes, speakers, convention attendees, students, institutions, media partners and guests for making Advanced Neurology 2019 a success and top-notch event.

Pulsus Group hosted the 3rd World Congress on Neurology and Therapeutics during October 07-08, 2019 in Madrid, Spain at Rafaelhoteles Forum Alcal with the theme Neurology! Heal the world of Neurological Impairments... Benevolent response and active participation was received from the Editorial Board Members of supporting International Journals as well as from the leading academic scientists, researchers, research scholars, students and leaders from the fields of Neurology, Neuroscience and neurotherapeutics who made this event successful.

The neurology conference turned into marked with the aid of the attendance of young and brilliant researchers, enterprise delegates and talented pupil communities representing greater nations, who've driven this event into the path of achievement. This neurology conference highlighted through diverse periods on Neurological issues studies.

Advanced Neurology 2019 witnessed an amalgamation of unparalleled speakers who enlightened the gathering with their knowledge and discussed on various new-fangled topics related to the fields of Neurological Disorders, Neurotherapeutics, Neuro-imaging, Neurology, Neuroscience.

The neurology congress proceedings were performed through various scientific sessions and plenary lectures. Neurology conference changed into embarked with an opening ceremony accompanied by way of a sequence of lectures introduced by way of both Honourable guests and contributors to the Keynote discussion board.

Jacques Fantini | Aix-Marseille University | France

Nouara Yahi | Aix-Marseille University | France

Originally posted here:
Neurology | Neurology conferences | Neuro congress ...

Neurologist weighs in on teen driving dangers as bill aims to change driving age in Ohio – WKYC.com

POWELL, Ohio Legislators in Ohio are currently considering a bill that would change the driving age for teens in Ohio. Ohio State Wexner Medical Center neurology experts provide new information to help form a better decision.

The bill would require teenage drivers under 18 years old to use their learner's permits for a full year before they can get a driver's license. If passed, minors would have to be at least 16 1/2 before they could get their probationary driver's license. The proposed legislation aims to give young drivers more experience behind the wheel prior to obtaining their license. The bill would extend the permit phase for minors from six months to 12 months.

RELATED: Proposed Ohio law would raise driving age

"I think 16 is the perfect age," said 16-year-old Anna Bean. "It allows us to get to the places we need to go for school, sports or a job."

But Anna Bean's mom is not so eager to hand over the keys.

"They are still learning and have not seen the aftermath of what happens," said mother Amy Bean.

Helping more people decide to buckle up and participate in safer driving practices are Amy Bean's life purpose. She was pushed to action within the community after a tragedy.

"16 years ago my husband died due to a drunk driving crash," said Bean.

Now, Bean works to make the roads safer through work with the group "Safe Delaware." She volunteers within the organization SAFE Delaware County.

SAFE stands for 'Safety Awareness for Everyone' and the coalition's purpose is to provide injury prevention awareness programs related to traffic safety and child safety. Bean said other parents who think the proposed delay for licenses is too much haven't seen the latest stats.

While parents and teens may debate the best age to drive, Ohio State Wexner Medical Center neurologist Dr. Kiran Rajneesh explains what science says.

"I think deciding the right age is a question for society, but one of the things as a neurologist that I focus on is how some of these experiences of driving impact brain development," said Dr. Rajneesh. "By the age of 16, the brain is structurally formed. But it is not matured yet. Complex planning, having the responsibility and having the ability to drive and be exposed to new experiences is crucial for brain development. So bumping the age back may hinder that exposure and experiences that are crucial in having these young adults develop into the well-adjusted adults we want them to develop into."

Rajneesh explained the human brain is structurally formed at 16 years old, however, the brain does not complete development and maturity until the mid-20s for most people. Because waiting until 25-years of age to drive seems unlikely, so Dr. Rajneesh says at the age of 16, most teens have responsible adults in the car guiding them to help develop those life lessons.

To learn more, just visit this website.

RELATED: Teen caught driving 105 mph blames too many hot wings, police say

RELATED: Driving Skills Pad helps teens 'take control' in Medina County

Continued here:
Neurologist weighs in on teen driving dangers as bill aims to change driving age in Ohio - WKYC.com

People with Neurological Disorders Have a Higher Risk of Committing Suicide – DocWire News

Having a diagnosis of a neurological disorder is associated with an increased risk of suicide, according to a recent study published in JAMA.

In this nationwide cohort study, researchers assessed 7,300,395 people 15 years and older living in Denmark from 1980 until 2016. They analyzed medical contact for head injury, stroke, epilepsy, polyneuropathy, diseases of myoneural junction, Parkinson disease, multiple sclerosis, central nervous system infections, meningitis, encephalitis, amyotrophic lateral sclerosis, Huntington disease, dementia, intellectual disability, and other brain diseases from 1977 through 2016.

The studys primary endpoint was defined as death by decide, and the researchers estimated this outcome using Poisson regressions, adjusted for sociodemographics, comorbidity, psychiatric diagnoses, and self-harm.

According to the results of the study, than 7.3 million individuals observed over 161.935,233 person-years, 35,483 died by suicide (median duration of follow-up, 23.6 years; interquartile range, 10.0-37.0 years; mean age, 51.9 years; SD, 17.9 years). Of those, the results showed that 14.7% were diagnosed with a neurological disorder, equivalent to a suicide rate of 44.0 per 100.000 person-years compared with 20.1 per 100,000 person-years among individuals not diagnosed with a neurological disorder.

The researchers observed that people diagnosed with a neurological disorder had an adjusted IRR of 1.8 (95% CI, 1.7 to 1.8) compared with those not diagnosed. The excess adjusted IRRs were 4.9 (95% CI, 3.5 to 6.9) for amyotrophic lateral sclerosis, 4.9 (95% CI, 3.1 to 7.7) for Huntington disease, 2.2 (95% CI, 1.9 to 2.6) for multiple sclerosis, 1.7 (95% CI, 1.6 to 1.7) for head injury, 1.3 (95% CI, 1.2 to 1.3) for stroke, and 1.7 (95% CI, 1.6 to 1.8) for epilepsy.

Moreover, the association varied according to time since diagnosis with an adjusted IRR for 1 to 3 months of 3.1 (95% CI, 2.7 to 3.6) and for 10 or more years, 1.5 (95% CI, 1.4 to 1.6, P<.001). Compared with those who were not diagnosed with a neurological disorder, those with dementia had a lower overall adjusted IRR of 0.8 (95% CI, 0.7 to 0.9), which was elevated during the first month after diagnosis to 3.0 (95% CI, 1.9 to 4.6; P<.001). The absolute risk of suicide for people with Huntington disease was 1.6% (95% CI, 1.0% to 2.5%).

The researchers wrote in conclusion that: In Denmark from 1980 through 2016, there was a significantly higher rate of suicide among those with a diagnosed neurological disorder than persons not diagnosed with a neurological disorder. However, the absolute risk difference was small.

Follow this link:
People with Neurological Disorders Have a Higher Risk of Committing Suicide - DocWire News

Repetitive Head Impacts: A One-Two Punch for Pro Fighters? – Medscape

Although both active and retired professional boxing and mixed martial arts (MMA) fighters experience brain volume loss after repetitive head impacts (RHIs), different brain regions are affected, a new study shows.

The distinction suggests that different pathways are at work in traumatic brain injury, the researchers conclude.

"The different regions that showed decline between active and retired fighters was one of the most important findings," lead author Charles Bernick, MD, MPH, of the Cleveland ClinicLou Ruvo Center for Brain Health in Las Vegas, Nevada, told Medscape Medical News.

"We speculate that the changes we saw in volumes of deep brain structures like the thalamus and corpus callosum in active fighters may represent the delayed effects of repeated axonal injury, whereas in the retired fighters, the volume changes in the hippocampus and amygdala may represent a neurodegenerative process," Bernick added.

The study was published online December 23, 2019, in Neurology.

Monitoring changes in regional brain volumes on MRI can be useful for following structural brain changes over time, prior research suggests.

The current study builds on previous investigations that linked RHIs to volume changes in specific brain regions. Those earlier studies, however, were cross-sectional, the authors note, and "less is known about using volumetric MRI techniques in a longitudinal manner in those exposed to RHI."

To learn more about the long-term effects of RHIs, the investigators assessed participants in the Professional Fighters Brain Health Study (PFBHS). The ongoing PFBHS started in 2011. Annual assessments include high-resolution T1-weighted anatomic MRI of boxers, MMA athletes, and age- and education-matched control persons. Participants also undergo computer-based cognitive testing, and they report RHI exposure history at each evaluation.

The study population of 204 participants included 50 active boxers, 100 active MMA fighters, 23 retired boxers, and 31 control persons. There were not enough retired MMA fighters to create that cohort.

The mean age of the active boxers was 29 years, and the mean number of fights was five. For active MMA athletes, the mean age was 29, and the mean number of fights was eight. For retired boxers, the mean age was 45 years, and the mean number of fights was 38. For the control group, the mean age was 31; none of the control persons had a history of head trauma.

Compared with control persons, active boxers experienced an average annual volume decrease of the left thalamus of 102.3 mm3/yr, a significant difference (P = .0004). They also displayed decreases in the mid anterior corpus callosum of 10.2 mm3/yr (P = .018) and in the central corpus callosum of 16.5 mm3/yr (P < .0001).

The active MMA fighters also experienced decreases over time, although these were less pronounced. The left thalamus decreased by 57.5 mm3/yr (P = .036), and the central corpus callosum decreased by 9.7 mm3/yr (P = .007).

The retired boxers experienced the most significant decreases in volume compared to control persons, but in different areas. For them, the left amygdala decreased by 32.1 mm3/year (P = .002); the right amygdala, by 30.6 mm3/yr (P = .008); and the right hippocampus, by 33.5 mm3/yr (P = .01).

Bernick and colleagues also assessed serum neurofilament light (NfL) levels. Higher NfL levels were found to be associated with significantly greater decreases in volumes of the left hippocampus, at 33.2 mm3/yr (P < .001), and of the mid anterior corpus callosum, at 7.68 mm3/yr (P = .015).

Among fighters with higher NfL levels, there was also a trend toward lower volumes of the left amygdala, the right thalamus, and the mid corpus callosum over time.

In contrast, higher baseline tau levels were not associated with regional volumetric changes.

Bernick and colleagues previously reported that active fighters have higher serum NfL levels in general compared to retired fighters or control persons. "Thus, the current finding that, within the active fighter group, those with higher baseline NfL levels were more likely to show regional volumetric decline suggests that this measure may have predictive properties in identifying individuals who may be at risk of ongoing structural brain injury," the researchers note.

"Whether cessation of exposure to RHI in those who have elevated NfL levels will halt this volume loss over time needs further investigation," they add.

The researchers found no significant differences in trajectory of cognitive test scores between control persons and active or retired fighters at a group level.

Potential limitations of the study include the fact that it included few women, making it difficult to assess for volume changes by sex. In addition, the average follow-up time was 2.6 years, which may limit the findings.

"Volumetric MRI brain imaging may be able to detect accumulating injury or disease progression in individuals who are exposed to extensive repetitive head impacts," Bernick said.

He added a caveat that the findings need to be validated in other populations in which repetitive head trauma occurs, such as military personnel or athletes who participate in other contact sports.

Going forward, the researchers also might explore whether a multimodal approach that combines volume measures with other potential biomarkers could improve detection of changes at an individual level. Furthermore, if the MRI volumetric measures are validated, they could serve as clinical trial outcomes in future studies of RHIs, Bernick said.

The differences in brain atrophy between active and retired fighters "is intriguing, suggesting that longitudinal MRIs may distinguish between injury responses triggered by recent and remote RHI exposures," Christopher D. Anderson, MD, and Jonathan Rosand, MD, write in an accompanying editorial.

"Atrophy over time in these brain regions could reflect the sequelae of ongoing axonal injury," they note. The decreases in amygdala and hippocampus volumes in the retired fighters could reflect a neurodegerative process, such as that described in Alzheimer disease and chronic traumatic encephalopathy.

They describe the study as "an important advance in the study of athletes subjected to RHI who are at risk for early and long-term neurologic complications." Strengths of the research include a relatively large population, inclusion of people with both recent and remote trauma, and a well-characterized control group, they add.

"Further imaging studies will be needed to replicate and extend these findings," conclude Anderson, who is affiliated with the Henry and Allison McCance Center for Brain Health, the Department of Neurology, and the Center for Genomic Medicine at Massachusetts General Hospital in Boston, and Rosand, who is affiliated with the Program in Medical and Population Genetics at the Broad Institute in Cambridge, Massachusetts.

Bernick received research funding from Ultimate Fighting Championship, Top Rank Promotions, Haymon Boxing, Bellator/Spike TV, and the UCLA Dream Fund. Anderson and Rosand have disclosed no relevant financial relationships.

Neurology. Published online December 23, 2019. Abstract, Editorial

Follow Damian McNamara on Twitter: @MedReporter. For more Medscape Neurology news, join us on Facebook and Twitter.

See the rest here:
Repetitive Head Impacts: A One-Two Punch for Pro Fighters? - Medscape

Neurology Ultrasonic Aspirators to Witness Increase in Revenues by 2019 2027 – Dagoretti News

The Most Recent study on the Neurology Ultrasonic Aspirators Market Research provides a profound comprehension of the various market dynamics like trends, drivers, the challenges, and opportunities. The report further elaborates on the micro and macro-economic elements that are predicted to shape the increase of the Neurology Ultrasonic Aspirators market throughout the forecast period (2019-2029).

The introduced study elucidates the crucial indicators of Market growth which comes with a thorough analysis of this value chain, CAGR development, and Porters Five Forces Analysis. This data may enable readers to understand the quantitative growth parameters of this international industry that is Neurology Ultrasonic Aspirators .

Analytical Insights Included from the Neurology Ultrasonic Aspirators Market Report

Request Sample Report @ https://www.transparencymarketresearch.co/sample/sample.php?flag=B&rep_id=72315

Neurology Ultrasonic Aspirators Market Segmentation Assessment

The increase prospects of this market in various Regions are studied in the report together with details like the regulatory framework, political, and financial outlook of each region.

Market segments and sub-segments

The regional analysis covers:

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

Note:Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request For Discount On This Report @ https://www.transparencymarketresearch.co/sample/sample.php?flag=D&rep_id=72315

The Report intends to eliminate the subsequent doubts regarding the Neurology Ultrasonic Aspirators market:

Reasons To Choose TMR:

RequestTOC For ThisReport @ https://www.transparencymarketresearch.co/sample/sample.php?flag=T&rep_id=72315

Go here to see the original:
Neurology Ultrasonic Aspirators to Witness Increase in Revenues by 2019 2027 - Dagoretti News

Prognosis for MS changing due to advancements in treatment and awareness, yet access to care is top of mind for neurologists – WFN News

The Prognosis for MS is Changing Due to Advancements in Treatment and Awareness, Yet Access to Care is Top of Mind for Global Neurologists

World Federation of Neurology: November 15, 2019 | London Are regulators keeping up with new treatments and management strategies that can greatly improve the lives of patients with multiple sclerosis (MS)? That question is being debated following the unveiling of significant clinical advances in the diagnostic criteria and treatment of MS at the XXIV World Congress of Neurology (WCN 2019) in Dubai, UAE.

MS has gone from being an untreatable condition to being a manageable disease which is an extraordinary story of achievement, but there is still a long way to go.

MS affects an estimated 2.3 million people around the world, and research shows that access to quality treatment is vital in altering the progression of the disease, especially during the inflammatory part of the disease.

On a global level, there is a concerning gap between the results of clinical trials and regulators approval of advanced therapies, leaving some patients without access to the most effective options.

In fact, therapeutic lags have resulted in entire regions where MS patients will be disabled for longer, due to restrictions or lags in regulatory approvals that restrict doctors from prescribing treatments with the best outcomes.

The understanding of the disease and disease phenotypes are changing, said Prof. Bill Carroll, president of the World Federation of Neurology (WFN) and neurologist at the Department of Neurology and Neurophysiology at the Sir Charles Gairdner Hospital in Perth, Western Australia.

To see improved developments in MS treatment and diagnosis, global awareness and advocacy are in order. International initiatives and awareness will help unlock greater funding for MS research and lead to more effective treatments, says Prof. Thompson.

Our patients should be the number one priority, and its time for neurologists and MS physicians to adopt the approach that they should consider prescribing what is most appropriate for their patients today, despite what restrictions may have put in place yesterday by regulators, said Prof. Carroll.

WCN 2019, hosted by the World Federation of Neurology, brought together leaders in neurology to present new research, hold educational sessions and inspire action on topics ranging from MS and migraine to epilepsy and climate change.

About the World Federation of Neurology

The World Federation of Neurology represents 120 member neurological societies around the globe to foster quality neurology and brain health worldwide by promoting neurological education and training with an emphasis on under-resourced areas of the world. WFN supports the spread of accurate research and clinical information in the pursuit of improvements in the field of neurology. With support from member organizations around the globe, WFN unites the world to allow patients greater access to brain health. For more information, please visit the WCN 2019 web site at http://www.wfneurology.org or by searching using the tag #WCN2019.

Media ContactYakkety Yak ContactAshley Logan, Yakkety Yak LLCpress@yakketyyak.com

See original here:
Prognosis for MS changing due to advancements in treatment and awareness, yet access to care is top of mind for neurologists - WFN News

Never before has it been more exciting and important to be a neurologist – Research in progress blog – BMC Blogs Network

Neurological Research and Practice, the official journal of the German Neurological Society, launched its submission system about 1 year ago. Wed like to take this opportunity to talk about hot topics in neurology and the journals first year, with Professor Gereon Fink, Past President of the German Neurological Society.

Victoria Hentschke 9 Dec 2019

What are the current trends and hot topics in neurology?

The increasing insights into the genetics and molecular bases of neurological disorders open new perspectives for specific and personalized treatments. This is evidenced most dramatically by the antisense therapy for spinal muscular atrophy. Promising neurological research currently targets neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinsons disease, Duchenne muscular atrophy, or Huntingtons disease. Likewise, brain-machine interfaces and neuroprosthetics offer huge potential. Never before has it been more important and more exciting to be a neurologist!

Neurological Research and Practice is celebrating its 1st anniversary of the submission system launch. As the Past President and one of the main drivers for the societys own English-language open access journal, what has the journal achieved so far? Are you happy with the progress you are seeing now?

Within only one year, a new journal has been established with a regular publication schedule of already 3 -4 articles per month with the first articles being published in February 2019. The article accesses of research articles, e.g., Safety and clinical impact of FEES results of the FEES registry, or review articles, e.g., Navigating choice in multiple sclerosis management, demonstrate that the topics covered in the journal meet the readers interests. In addition to review and research articles, standard operating procedures, guidelines, and clinical trial protocols provide a modern style that attracts clinically oriented neuroscientists and neurologists as the target group of Neurological Research and Practice. All this proves that the conceptualization of the journal has been successful. Given the wealth of journals and the competition in the field, we are delighted with the positive reception of Neurological Research and Practice. I would like to congratulate the Editor-in-Chief, Werner Hacke, and his team for the great job they have done.

Lets take a step back why did the DGN wanted to have an open access journal? What was the idea and mission behind the journal?

Without any doubt, neurology is the key discipline in medicine of the 21st century, given the sociodemographic changes of our societies. At the same time, never before in the history of neurology, have we seen such tremendous scientific breakthroughs in basic, clinically relevant neuroscience, translational neurology, and clinical practice. Just think about the significant advances in the treatment of stroke or multiple sclerosis. Thus, bringing together neurological research and practice has proven fruitful. Few journals, however, specifically aim at bridging basic, clinically relevant neuroscience and clinical practice. Neurological Research and Practice, the official journal of the German Neurological Society, exactly aims to do that with a broad scope reflecting all clinical, translational and basic research aspects of neurology and neuroscience. NRP provides a forum for clinicians and scientists with an interest in all areas of neurology including, but not limited to, genetics, vascular diseases and critical care, disorders of the spine, movement disorders, neuroimmunology, infections, oncology, epilepsy, neuroimaging and neuroradiology, neurodevelopment and degeneration.

What are you expecting for the journals future in the next year?

Although online only since February 2019, NRP is already well-perceived, and the first citations speak to the relevance and timeliness of the articles published. The next steps include indexing in the National Library of Medicine (NLM). This will allow access to PubMed and other databases, which will significantly enhance NRPs visibility. Although NRP is the official journal of the German Neurological Society, the journal aims to bring together authors and readers from all countries worldwide. Besides, access to NLM will also be an important step for gaining an impact factor. Given NRPs success over the first few months, we are confident that these important milestones can be achieved in the near future, and hope for this to be within the next 24 months.

Read this article:
Never before has it been more exciting and important to be a neurologist - Research in progress blog - BMC Blogs Network